SCHEMBL9199100

SCHEMBL9199100

O=C1c2ccccc2C2(c3cccc4[nH]c5ccccc5c34)SCCCN12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
NPC1 O15118 1/20 0.34
POLB P06746 1/20 0.34
ADRB2 P07550 2/20 0.34
ADRB1 P08588 2/20 0.34
ADRB3 P13945 2/20 0.34
CDK4 P11802 6/20 0.33
CCND1 P24385 6/20 0.33
CCNE2 O96020 3/20 0.33
CCNE1 P24864 3/20 0.33
CDK2 P24941 3/20 0.33
CCNB2 O95067 2/20 0.33
CDK1 P06493 2/20 0.33
CCNB1 P14635 2/20 0.33
PRKACA P17612 2/20 0.33
PRKACG P22612 2/20 0.33
PRKACB P22694 2/20 0.33
CAMK2B Q13554 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9700477 0.82 GAA (0.42) KDM4ENPC1POLBCDK4CCND1
SCHEMBL9195253 0.81 SLC6A3 (0.38) PARP1KDM4EALDH1A1NPC1POLB
SCHEMBL9207191 0.80 IMPDH2 (0.35) PARP1CDK4CCND1CCNE2CCNE1
SCHEMBL9206027 0.80 PARP14 (0.37) KDM4EALDH1A1NPC1POLBCDK4
SCHEMBL9739157 0.79 PARP1 (0.39) PARP1KDM4EALDH1A1NPC1POLB
SCHEMBL9268715 0.77 BRD4 (0.35) PARP1NPC1POLB
SCHEMBL9700348 0.77 CES1 (0.36) PARP1NPC1POLBHTTSMN1; SMN2
SCHEMBL9701779 0.76 NPC1 (0.34) PARP1NPC1POLBHTTSMN1; SMN2
SCHEMBL9201756 0.76 NPC1 (0.48) KDM4ENPC1POLBHTTSMN1; SMN2
SCHEMBL9701851 0.76 TSHR (0.37) KDM4EALDH1A1NPC1POLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0682523-A1 USE OF TRICYCLIC ISOINDOLINONES AS ANTIVIRAL DRUGS, AND NEW, OPTICALLY ACTIVE ISOINDOLINONES Roche Diagnostics GmbH (DE) 1995-11-22 EP disclosed
WO-1992015310-A1 USE OF TRICYCLIC ISOINDOLINONES AS ANTIVIRAL DRUGS, AND NEW, OPTICALLY ACTIVE ISOINDOLINONES BOEHRINGER MANNHEIM GMBH (DE) 1992-09-17 WO disclosed